Charles River licenses rodent model for global diabetes reserach
Charles River Labs enters a licensing agreement with Crown Bioscience to expand access to the latter’s diabetic rat model.
Charles River Labs enters a licensing agreement with Crown Bioscience to expand access to the latter’s diabetic rat model.
Premier Research looks to “put a finger” on what patient-centricity means with the launch of a new patient and stakeholder engagement capability.
The clinical informatics company Ovation.io secures $5m in Series A funding to expand its platform designed to help diagnostic labs become a “keystone of precision medicine in their community,” says CEO.
Noramco partners with Nemus to produce an analogue of cannabidiol that possesses greater bioavailability, that could be used to treat diseases of the retina.